Logo

Transgenomic Opening PGx Services Lab in China

Apr 01, 2008
NEW YORK (GenomeWeb News) – Transgenomic said today it has entered into a laboratory services partnership agreement with the Guangzhou Family Planning Center in China that it will use to provide pharmacogenomic analysis services to pharmaceutical companies seeking to perform clinical trials in China.
 
Transgenomic said it has already equipped the Guangzhou facility with the technology necessary to provide pharmacogenomics services.
 
Transgenomic President and CEO Craig Tuttle said the agreement provides the firm with the lab it needs to open “significant new clinical testing opportunities for us.”
 

Breaking News
The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.